Patent ID: 9447193
Filing Date: 2016-09-20
CPC Classification: A61K,A61P,C07K,C12Q,G01N

Claim Text:
1. A method for treating cancer, comprising: administering to a subject in need thereof an antibody against a transmembrane and coiled-coil domains protein 3 (TMCC3), wherein the antibody binds to an epitope in an extracellular domain of TMCC3, wherein the antibody has a heavy chain and a light chain, wherein the heavy chain having complementary determination regions (CDRs) consisting of CDRH1, CDRH2, and CDRH3, wherein the light chain having CDRs consisting of CDRL1, CDRL2, and CDRL3, wherein CDRH1, CDRH2, and CDRH3 comprise respectively the sequences of SEQ ID NO: 13, SEQ ID NO: 14, and SEQ ID NO: 15, wherein CDRL1, CDRL2, and CDRL3 comprise respectively the sequences of SEQ ID NO: 16, SEQ ID NO: 17, and SEQ ID NO: 18.